Agenda

Wednesday, January 21, 2009

Retinal “Science Fiction”: Novel Drugs and Techniques
Moderator: Jay S. Duker, MD
6:30 – 7:30 am	Diseases of the Retina: Emerging Science 2009, supported by Allergan
7:30 – 7:34	Announcements
7:35 – 7:55	New Pharmacologic Approaches to Wet AMD Steven D. Schwartz, MD
7:56 – 8:16	Integrin Antagonists and other New AMD Therapies Peter K. Kaiser, MD
8:17 – 8:37	Pazopanib: A Small Molecule VEGF-Receptor Inhibitor for Exudative AMD Elias Reichel, MD
8:38 – 9:04	VEGF Trap Update Peter K. Kaiser, MD
9:05 – 9:34	Break
9:35 – 9:55	Current Concepts of Central Serous Choroidopathy Anne E. Fung, MD
9:56 – 10:06	Bevacizumab vs. Ranibizumab: A Head-to-Head Trial at the Boston VA Hospital Manju L. Subramanian, MD
10:07 – 10:37	Late Breaking Results
10:38 – 11:08	Break

Retinal Vascular Disease Symposium: Diabetes and Venous Occlusion
11:09 – 11:26	Intravitreal Triamcinolone vs. Laser for DME Michael S. Ip, MD
11:27 – 11:44	Anti-VEGF Therapy for Diabetic Macular Edema Dean Eliott, MD
11:45 – 12:02 pm	Future Treatments for Diabetic Retinopathy SriniVas R. Sadda, MD
12:03 – 12:30	Sustained-Release Steroid Devices for Diabetic Macular Edema Dean Eliott, MD